CG
CLB icon

Cutler Group’s Core Laboratories CLB Stock Holding History

Cutler Group’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,400
Closed -$122K – 4981
2017
Q3 		$122K Sell
6,400
-10,700
-63% -$1.04M ﹤0.01% 1500
2017
Q2 		$174K Buy
17,100
+12,900
+307% +$1.39M 0.01% 1395
2017
Q1 		$28K Buy
4,200
+2,900
+223% +$337K ﹤0.01% 2977
2016
Q4 		$14K Sell
1,300
-11,900
-90% -$1.32M ﹤0.01% 3815
2016
Q3 		$24K Buy
13,200
+2,200
+20% +$253K ﹤0.01% 3222
2016
Q2 		$9K Sell
11,000
-3,000
-21% -$362K ﹤0.01% 4254
2016
Q1 		$23K Buy
14,000
+7,000
+100% +$727K ﹤0.01% 3123
2015
Q4 		$46K Buy
+7,000
New +$801K ﹤0.01% 2553

Other funds holding CLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Cutler Group's CLB Position: Q2 2021 in Review

Cutler Group sold out of Core Laboratories (CLB) in Q2 2021, closing a stake of 230 shares — an estimated $8.24K sold.

Cutler Group first reported a position in CLB in Q4 2015 and held it in 11 quarters. The position peaked at $990K in Q3 2016. 195 funds tracked by Wall St. Rank hold CLB as of Q2 2021.

  • Cutler Group reported no remaining Core Laboratories position as of Q2 2021 after selling out during the quarter.
  • Cutler Group sold 230 Core Laboratories shares in Q2 2021, an estimated $8.24K.
  • Cutler Group first reported a position in Core Laboratories in Q4 2015 and held it in 11 quarters.
  • Cutler Group's Core Laboratories position peaked at $990K in Q3 2016.
  • 195 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2021.

Based on Cutler Group's 13F filing for Q2 2021, filed 19 Jul 2021.